Abbott and Reckitt’s Mead Johnson face over 1,000 claims that preterm infant formula causes necrotizing enterocolitis (NEC) in infants and have been hit with jury verdicts totaling a half a billion dollars so far. In this Votes and Verdicts podcast, Bloomberg Intelligence litigation analysts Holly Froum and Justin Teresi discuss federal and state litigation, key catalysts in 2025, potential exposure, potential settlement value and more.

See omnystudio.com/listener for privacy information.

A key ruling in TikTok’s lawsuit challenging the US “sale or ban” law, a trial in Arm v. Qualcomm litigation over chip-licensing and oral arguments in a Canadian Pacific bondholder appeal in a $2.4 billion suit over redemption rights are litigation catalysts to watch in December. In this Votes and Verdicts episode, Bloomberg Intelligence senior litigation analyst Elliott Stein gathered colleagues to discuss these and other themes. These include expected verdicts in DOJ v. Google over ad tech, in the FTC’s suit in Oregon against the Kroger-Albertsons merger and in a $750 million PCB contamination trial against Bayer/Monsanto. Also discussed were President Biden’s plan to cover anti-obesity drugs under Medicare and Medicaid, deregulation in the financials sector and why crypto is poised to do well with Trump’s victory.

See omnystudio.com/listener for privacy information.

After Donald Trump’s Nov. 5 election win, technology, media and telecom companies in the US will likely see major changes in the US regulatory environment. In this episode of the Votes and Verdicts podcast, Bloomberg Intelligence senior litigation analyst Jennifer Rie joined fellow BI analyst Matthew Schettenhelm to discuss what the election may mean for internet platforms, broadband-service providers and broadcasters.

See omnystudio.com/listener for privacy information.